GENOMOM - NIPT(Non-Invasive Prenatal Test) Service

GENOMOM - NIPT(Non-Invasive Prenatal Test) Service


Negotiable Min Order Quantity Unit

Required Quantity
Place of Origin
South Korea
Payment Terms
Negotiable
Production method
Negotiable
Shipping / Lead Time
Negotiable / Negotiable
Keyword
ngs, napt, informatics, non invasive prenatal test
Category
Monitoring & Diagnostic Equipment , Other Monitoring & Diagnostic Equipment
tK Meet
tK Meet

Apply a video call to the Supplier

SEND TO SUPPLIER INQUIRY

GENOMECARE CO LTD

Membership
PRO
Country / Year Established
South Korea South Korea / 2012
Business type
Manufacturer
Verified Certificate

7

DUNS

Product name GENOMOM - NIPT(Non-Invasive Prenatal Test) Service Certification -
Category Monitoring & Diagnostic Equipment
Other Monitoring & Diagnostic Equipment
Ingredients -
Keyword ngs , napt , informatics , non invasive prenatal test Unit Size -
Brand name - Unit Weigh -
origin South Korea Stock -
Supply type - HS code -

Product Information

 

 

GENOMOM - NIPT(Non-Invasive Prenatal Test) Service 



│ DESCRIPTION │

 

 

* Q. What is NGS? NGS stands for “Next Generation Sequencing”, the advanced technology of DNA sequencing with fast, accurate and high output performance. 

 

* Q. What is Genomom for NIPT Method?NIPT is a screening method for detecting certain specific chromosomal abnormalities in a developing baby. After 10 weeks of pregnancy, NIPT can detect whether your baby is at risk of fetal trisomy 13, 18 and 21 (Patau syndrome, Edwards syndrome, and Down syndrome) accurately.

 

* NIPT Process1. Draw blood sample from pregnant women(From 10weeks)
2. Q.C
3. Library Construction
4. DNA Sequencing
5. Sequencing Data Analysis
6. Detect fetal defect probability

 

* Accuracy and reliabilityNIPT using next generation sequencing technology have been delivered more accurate results for prenatal test of fetal abnormality since 2012 in US and other advanced personal genome analysis markets. Notable papers were published in major journal such as NATURE, PNAS and still related papers are publishing in main streams. Nevertheless of bit differences, NIPT results maintain over 99% accuracy.
The Newest NGS technologies, chromosomal abnormalities are non-invasively detectable with over 99% confident sensitivity and specificity level. As result, NIPT are now evolving toward favorable and affordable prenatal diagnosis technique. NIPT is a screening method for detecting certain specific chromosomal abnormalities in a developing baby. After 10 weeks of pregnancy, NIPT can detect whether your baby is at risk of fetal trisomy 13, 18 and 21 (Patau syndrome, Edwards syndrome, and Down syndrome) accurately.
NIPT using next generation sequencing technology have been delivered more accurate results for prenatal test of fetal abnormality since 2012 in US and other advanced personal genome analysis markets. Notable papers were published in major journal such as NATURE, PNAS and still related papers are publishing in main streams. Nevertheless of bit differences, NIPT results maintain over 99% accuracy.

 

 

editorimg editorimg

 

 

 

 

 


 

B2B Trade

Price (FOB) Negotiable transportation -
MOQ Negotiable Leadtime Negotiable
Payment Options Negotiable Shipping time Negotiable

GENOMECARE CO LTD

Country / Year Established
South Korea South Korea / 2012
Membership
PRO
Business type
Manufacturer

7

DUNS

President
MyungJun Jeong
Address
Bdong 4F, Gwanggyuoro 145, Yeongtong-gu, Suwon-si, Gyeonggi-do, KOREA
Product Category
Medical Test Kit
Year Established
2012
No. of Total Employees
1-50
Company introduction

We, Genomecare co,Ltd.,are looking for Overseas Sales Partnership as a distributor or an Exclusive Partner(Technology Transfer).

Genomcare is serving NIPT (Non-invasive prenatal Test) &PGS (Pre-implantation genetic Screening) base on NGS(Next generation Sequencing) service to our customer utilizing proton and S5XL (ThermoFisher) which are screening chromosomal abnormalities of Fetus and maternal and performed on Embryo during IVF treatment to screen for numerical chromosomal abnormalities.

We published the clinical results of NIPT in PLOS ONE&BMC Medical Genomics(Oct 2014, April 2016, Oct 2016) worldwide authoritative scientific journal. Through these experiments, Genomecare became the first sacrificially verified NIPT service provider in Korea with world-class level of NGS and data analysis competency.

ION PROTON

The Ion Proton system makes affordable, high-quality next-generation sequencing to elucidate vriants important for the heritability of cancer as well as Mendelian and complex disorders.

Exome sequecning is a targeted sequencing approach that is restricted the protein-coding region of genomes. The exome is estimated to encompass approximately 1% of the genome, yet contains approximately 85% of disease-causing mutations. For genetic researchers trying to unravel the disease-causing genes of over 6,800 rare disease, exome sequencing enables the identification of common single-nucleotide variants(SNVs) and small insertions or deletions (indels), as well as rare de novo mutations that may explain the heritabiltiy of Mendelian and complex disorders.  

Main Markets

Indonesia Indonesia

Philippines Philippines

Singapore Singapore

South Korea South Korea

Thailand Thailand

Viet Nam Viet Nam

Main Product

Related Products

Other buyers also search

Membership Grade

BUYER

Biz Pro VIP

SELLER

Biz Pro VIP
팝업닫기
Live Chat A new message arrives
from a business partner.

No Data

  • There is no data to load
  • Check out the My tK > My Inquiries list.
  • After agreeing to the use of the Live Chat service, the list is printed only when there is at least one history of receiving or sending a Live Chat request.

If you have not yet agreed to use the Live Chat service,

You can use the Live Chat freely after agreeing to the use of the Live Chat service.

View more
View more